QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: jpet.103.053074v1 307/1/322    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Urwyler, S. Articles by Kaupmann, K. Search for Related Content PubMed PubMed Citation Articles by Urwyler, S. Articles by Kaupmann, K.

NEUROPHARMACOLOGY

N,N'-Dicyclopentyl-2-methylsulfanyl-5-nitro-pyrimidine-4,6-diamine (GS39783) and Structurally Related Compounds: Novel Allosteric Enhancers of -Aminobutyric Acid_B Receptor Function

Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland

N,N'-Dicyclopentyl-2-methylsulfanyl-5-nitro-pyrimidine-4,6-diamine (GS39783) and structurally related compounds are described as novel allosteric enhancers of GABA_B receptor function. They potentiate GABA-stimulated guanosine 5'-O-(3-[³⁵S]thio)triphosphate ([³⁵S]GTPS) binding to membranes from a GABA_B(1b/2)-expressing Chinese hamster ovary cell line at low micromolar concentrations, but do not stimulate [³⁵S]GTPS binding by themselves. Similar effects of GS39783 are seen on native GABA_B receptors in rat brain membranes. Concentration-response curves with GABA in the presence of different fixed concentrations of GS39783 reveal an increase of both the potency and maximal efficacy of GABA at the GABA_B(1b/2) heterodimer. In radioligand binding experiments, GS39783 reduces the kinetic rate constants of the association and dissociation of [³H]3-aminopropylphosphinic acid, resulting in a net increase in affinity for the agonist radioligand. In equilibrium binding experiments (displacement of the antagonist ligand [³H]CGP62349), GS39783 increases agonist affinities. Agonist displacement curves are biphasic, probably reflecting the G protein-coupled and uncoupled states of the receptor. The proportion of the high-affinity component is increased by GS39783, suggesting that the G protein coupling of the receptor is also promoted by the positive modulator. We also show that GS39783 has modulatory effects in cellular assays such as GABA_B receptor-mediated activation of inwardly rectifying potassium channels in Xenopus oocytes and Ca²⁺ signaling in human embryonic kidney 293 cells. In a more physiological context, GS39783 is shown to suppress paired pulse inhibition in rat hippocampal slices. This effect is reversed by the competitive GABA_B receptor antagonist CGP55845A and is produced most likely by enhancing the effect of synaptically released GABA at presynaptic GABA_B receptors.

Address correspondence to: Dr. Stephan Urwyler, Novartis Institutes for BioMedical Research, Novartis Pharma AG, WKL-125.11.03, CH-4002 Basel, Switzerland. E-mail: stephan.urwyler{at}pharma.novartis.com

This article has been cited by other articles:

				N. E. Paterson, S. Vlachou, S. Guery, K. Kaupmann, W. Froestl, and A. Markou Positive Modulation of GABAB Receptors Decreased Nicotine Self-Administration and Counteracted Nicotine-Induced Enhancement of Brain Reward Function in Rats J. Pharmacol. Exp. Ther., July 1, 2008; 326(1): 306 - 314. [Abstract] [Full Text] [PDF]

				C. Mombereau, L. Lhuillier, K. Kaupmann, and J. F. Cryan GABAB Receptor-Positive Modulation-Induced Blockade of the Rewarding Properties of Nicotine Is Associated with a Reduction in Nucleus Accumbens {Delta}FosB Accumulation J. Pharmacol. Exp. Ther., April 1, 2007; 321(1): 172 - 177. [Abstract] [Full Text] [PDF]

				D. S. Dupuis, D. Relkovic, L. Lhuillier, J. Mosbacher, and K. Kaupmann Point Mutations in the Transmembrane Region of GABAB2 Facilitate Activation by the Positive Modulator N,N'-Dicyclopentyl-2-methylsulfanyl-5-nitro-pyrimidine-4,6-diamine (GS39783) in the Absence of the GABAB1 Subunit Mol. Pharmacol., December 1, 2006; 70(6): 2027 - 2036. [Abstract] [Full Text] [PDF]

				Y. Chen, N. Menendez-Roche, and E. Sher Differential Modulation by the GABAB Receptor Allosteric Potentiator 2,6-Di-tert-butyl-4-(3-hydroxy-2,2-dimethylpropyl)-phenol (CGP7930) of Synaptic Transmission in the Rat Hippocampal CA1 Area J. Pharmacol. Exp. Ther., June 1, 2006; 317(3): 1170 - 1177. [Abstract] [Full Text] [PDF]

				D. A. Slattery, S. Desrayaud, and J. F. Cryan GABAB Receptor Antagonist-Mediated Antidepressant-Like Behavior Is Serotonin-Dependent J. Pharmacol. Exp. Ther., January 1, 2005; 312(1): 290 - 296. [Abstract] [Full Text] [PDF]

				J. F. Cryan, P. H. Kelly, F. Chaperon, C. Gentsch, C. Mombereau, K. Lingenhoehl, W. Froestl, B. Bettler, K. Kaupmann, and W. P. J. M. Spooren Behavioral Characterization of the Novel GABAB Receptor-Positive Modulator GS39783 (N,N'-Dicyclopentyl-2-methylsulfanyl-5-nitro-pyrimidine-4,6-diamine): Anxiolytic-Like Activity without Side Effects Associated with Baclofen or Benzodiazepines J. Pharmacol. Exp. Ther., September 1, 2004; 310(3): 952 - 963. [Abstract] [Full Text] [PDF]

				V. Binet, C. Brajon, L. Le Corre, F. Acher, J.-P. Pin, and L. Prezeau The Heptahelical Domain of GABAB2 Is Activated Directly by CGP7930, a Positive Allosteric Modulator of the GABAB Receptor J. Biol. Chem., July 9, 2004; 279(28): 29085 - 29091. [Abstract] [Full Text] [PDF]